Cargando…
PPAR and functional foods: Rationale for natural neurosteroid-based interventions for postpartum depression
Allopregnanolone, a GABAergic neurosteroid and progesterone derivative, was recently approved by the Food and Drug Administration for the treatment of postpartum depression (PPD). Several mechanisms appear to be involved in the pathogenesis of PPD, including neuroendocrine dysfunction, neuroinflamma...
Autores principales: | Matrisciano, Francesco, Pinna, Graziano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226878/ https://www.ncbi.nlm.nih.gov/pubmed/32426424 http://dx.doi.org/10.1016/j.ynstr.2020.100222 |
Ejemplares similares
-
Composite contributions of cerebrospinal fluid GABAergic neurosteroids, neuropeptide Y and interleukin-6 to PTSD symptom severity in men with PTSD
por: Kim, Byung Kil, et al.
Publicado: (2020) -
Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
por: Zorumski, Charles F., et al.
Publicado: (2019) -
Allopregnanolone: From molecular pathophysiology to therapeutics. A historical perspective
por: Paul, Steven M, et al.
Publicado: (2020) -
Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
por: Meltzer-Brody, Samantha, et al.
Publicado: (2020) -
Allopregnanolone-based treatments for postpartum depression: Why/how do they work?
por: Walton, Najah, et al.
Publicado: (2019)